Riva M, Wouters R, Sterpin E, Giovannoni R, et al. Radiotherapy, Temozolomide, and Antiprogrammed Cell Death Protein 1 Treatments Modulate the Immune Microenvironment in Experimental High-Grade Glioma. Neurosurgery 2020 Dec 8. pii: 6027136. doi: 10.1093.
PMID: 33289503